000			01665 a2200517 4500
005			20250513110938.0
264		0	_c19970403
008			199704s 0 0 eng d
022			_a0902-0063
040			_aNLM _beng _cNLM
100	1		_aGotti, E
245	0	0	_aEarly ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia. _h[electronic resource]
260			_bClinical transplantation _cDec 1996
300			_a550-5 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntigens, Viral _xblood
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aChemoprevention
650	0	4	_aChild
650	0	4	_aCytomegalovirus _xdrug effects
650	0	4	_aCytomegalovirus Infections _xprevention & control
650	0	4	_aDrug Monitoring
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aFoscarnet _xtherapeutic use
650	0	4	_aGanciclovir _xtherapeutic use
650	0	4	_aGraft Survival
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKidney Transplantation
650	0	4	_aLeukocytes _xvirology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRisk Factors
650	0	4	_aSurvival Rate
650	0	4	_aViremia _xprevention & control
700	1		_aSuter, F
700	1		_aBaruzzo, S
700	1		_aPerani, V
700	1		_aMoioli, F
700	1		_aRemuzzi, G
773	0		_tClinical transplantation _gvol. 10 _gno. 6 Pt 1 _gp. 550-5
999			_c8987982 _d8987982